Member Info for Chrisatrdg

Following my earlier post I have just increased my investment by 250,000 shares (cost �825) now at 1,000,000.I am fully confident that this project will be a success.Onwards & upwards.

Well that was a bolt from the blue & supports my mantra for the last year or so that the INFA project is too big to fail.In some ways the interview was as good as any RNS.I sold some shares this Tuesday required for work on the house in June/July but now tempted to make a further top up.We are clearly out of the last chance saloon but for me to break even the SP has to be 0.61 (increase of 184.85%).Having worked as an accountant in the offshore oil industry in the UK can appreciate where this project could lead too.Onwards & upwards.

Hi All - Good to see the second RNS relating to Summits new Discuva platform just need someone to explain it all but also good that there will be a further update H2 2018.Onwards & upwards.We may get a more positive reaction on the NASDAQ.

Summit Therapeutics completes dosing of ezutromid in PhaseOut DMD clinical trial: http://www.proactiveinvestors.co.uk/companies/news/195368

I saw the red dot too gmcc & Summit seem to be cracking on at a great pace this is good news today for once no delays.Onwards & upwards.

A simple comment WOW !!!!!!!!

Physiomics tweet 10 mins ago: @Physiomics is currently at #AACR2018 in Chicago, with an estimated 23k attendees from industry and academia. Both the company's stand and poster presentation have been well attended. We've met with a number of existing and potential new customers!

Sierra Oncology Progress with ongoing trials and future plans - see link below http://www.edisoninvestmentresearch.com/research/report/sierra-oncology367072/preview/

The current SP is woefully low hopefully the attached posters may change the situation: http://investor.sierraoncology.com/publications

Hi spudtheplumber - I like your positivity & totally agree with you.Onwards & upwards.

I note the SP is 'Building nicely' this morning hopefully this will continue today.Strong Buy at these prices provided one is prepared to take the risk.

Good read: http://www.proactiveinvestors.co.uk/companies/news/194744

I agree with you Walkley & support your view that SUMM is a 'Strong Buy' Below is a posting from waterloo01 from the other board: 'So much hangs on the 48wk data but the FDA paper recently does back up the MRI endpoint and good to hear Roblin reference it. If they get accelerated approval (some months after the results) then SRPT milestone kicks in.'

Hi All - Today is good news for all investors as the project can now move on & although I only had 600,000 shares I have just topped up this morning a mere 150,000 shares at 0.2538 (currently broke & waiting for new tax year).Looking forward to the next update & the subsequent price rise showing as Strong Buy for those prepared to take the risk.

Maybe will learn a little more & show support for yesterdays additional funding.

It is quite possible that the Company is in a 'purdah' period caused by them being in the middle of negotiations hence 'radio silence' so hang in there.I give it to the end of the month.Showing as a strong Buy but only if one is prepared to take the risk.

I agree with dawski37 it looks to me that we may have an avenue for INFA funding & I support showing as a Strong Buy.

Sareum update reveals extent of progress made by co's licence partner: Looking at the article you would have thought the SP would have increased but not on AIM http://www.proactiveinvestors.co.uk/companies/news/193047/sareum-update-reveals-extent-of-progress-made-by-co-s-licence-partner-193047

Hi All - Looks like someone is confident in INFA with their 2.5m Buy this morning lets hope we have a positive RNS soon I for one am hoping for an update by the end of March.

Hi rotivatorman - I totally agree with your posting & have always thought that the robust nature of this current DMD trial was to support a possible early submission to the FDA.